5-fluorouracil/salicylic acid topical solution
Term · Oncology and biomedicine · MLC-T-ONC-009553
A topical formulation containing 0.5 % of antimetabolite 5-fluorouracil (5-FU) and 10% of salicylic acid, with potential antimitotic and keratolytic activity. Upon cutaneous application, 5-FU in the 5-fluorouracil/salicylic acid topical solution impedes pyrimidine metabolism thereby inhibiting cell growth, while the salicylic acid induces anti-inflammatory response and results in keratolytic effect. This may result in the breakdown of keratinocytes and prevent proliferation of keratinocytes locally.
| Identifier | MLC-T-ONC-009553 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | low-dose 5-fluorouracil/salicylic acid |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009553",
"term": "5-fluorouracil/salicylic acid topical solution",
"field": "Oncology and biomedicine",
"definition": "A topical formulation containing 0.5 % of antimetabolite 5-fluorouracil (5-FU) and 10% of salicylic acid, with potential antimitotic and keratolytic activity. Upon cutaneous application, 5-FU in the 5-fluorouracil/salicylic acid topical solution impedes pyrimidine metabolism thereby inhibiting cell growth, while the salicylic acid induces anti-inflammatory response and results in keratolytic effect. This may result in the breakdown of keratinocytes and prevent proliferation of keratinocytes locally.",
"synonyms": [
"low-dose 5-fluorouracil/salicylic acid"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/5-fluorouracil-salicylic-acid-topical-solution/"
}
Record 109 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.